1-1 of 1
Michael Cukan, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

KPMW135, a Biosuperior CD3 Bispecific Version of Rituximab Created By a Novel Chemical Conjugation Technology Demonstrates Increased Anti-Tumor Activity By Adding T Cell-Mediated Cytotoxicity Activity to the Existing Mechanisms of Rituximab

Christian Vidal, PhD, Michael Cukan, PhD, Ada Vaill, MS, Anna Bunin, PhD, Ann Marie Rossi, MS, Lawrence Iben, MA, David Trinh, BS, Katy McGrath, BS, Tanya Berbasova, PhD, Rizwan Romee, MD, Enrique Alvarez, DVM, Luca Rastelli, PhD, Matthew Welsch, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-142113
Published: 2020